Stay Updated with the Latest Genmab A/S GMAB News in Real Time
Find GMAB news now at Meyka AI. Stay informed with the latest Genmab A/S stocks updates, including price news, market analysis, and expert insights.
Roche Share Price Dips After UBS Downgrade to Neutral
UBS cut Roche to Neutral on November 2 but raised its target to CHF 420. We explain why the Roche share price slipped to CHF 397.20, what giredestrant means and what analysts expect next.
GMAB Maintained at Buy by Deutsche Bank, May 2026
Deutsche Bank maintains GMAB at Buy rating with price target lowered to DKK 2,250 from DKK 2,400.
GMAB Earnings Preview: Genmab Q1 2026 on May 7
Genmab (GMAB) reports Q1 2026 earnings May 7. Analysts expect $0.15 EPS, $905.77M revenue. Stock at $27.52.
BNTX Stock Today: Founders to Exit; PT Cut to $167 – March 12
BNTX stock today: founders to exit by 2026 and Clear Street cuts price target to $167. What this means for leadership, IP, valuation, mRNA pipeline, and key trading levels for German investors.
BNTX News Today: BioNTech Stock Rises Sharply on Promising mRNA Flu-V3
BioNTech shares surge with promising interim results from its mRNA-based flu vaccine trial, signaling potential beyond COVID-19.